Drug and Therapeutics Committee Formulary 12 th Edition Version14.1 May 2015 Compiled on behalf of the Drug and Therapeutics Committee by Eleanore Atkinson Medicines Information Pharmacist Formulary 12 th Edition [v14.1] Contents Introduction ..................................................................................................................................... 11 Purpose ............................................................................................................................................... 11 How to use this Formulary .................................................................................................................. 11 Prescribing Formulary drugs............................................................................................................... 11 Prescribing a non-Formulary drug ...................................................................................................... 11 Procedure for additions to and amendment of the Formulary ............................................................. 11 Prescribing information ....................................................................................................................... 12 Filling in prescription charts ............................................................................................................... 12 Intravenous antibiotics ........................................................................................................................ 12 Controlled drugs ................................................................................................................................. 12 Discharge prescriptions ...................................................................................................................... 12 Out-patient prescriptions .................................................................................................................... 13 Hospital staff prescriptions ................................................................................................................. 13 Policy for personal prescribing by medical staff ................................................................................. 13 Unlicensed medicines ......................................................................................................................... 14 Policy for the use of unlicensed medicinal products ........................................................................... 14 Ward stock .......................................................................................................................................... 15 Patients own drugs .............................................................................................................................. 15 Substitution ......................................................................................................................................... 15 Clinical trials....................................................................................................................................... 15 Pharmacy information ......................................................................................................................... 16 Opening Hours .................................................................................................................................... 16 Medicines Information service - RBH ext. 7803 ................................................................................ 16 Ward pharmacy ................................................................................................................................... 16 Other information................................................................................................................................. 16 Drug representatives ........................................................................................................................... 16 Drug samples ...................................................................................................................................... 16 Adverse drug reaction (ADR) reporting ............................................................................................. 16 Other relevant publications ................................................................................................................. 16 Acknowledgements ............................................................................................................................. 17 0: Emergency treatment of poisoning .............................................................................................. 18 0.1 General Management of Poisoning ............................................................................................... 18 0.2 Activated charcoal .......................................................................................................................... 18 0.3 Availability of Antidotes ................................................................................................................ 19 1: Gastro-intestinal system .............................................................................................................. 20 1.1. Antacids and other drugs for dyspepsia ................................................................................. 20 1.2. Antispasmodics and other drugs altering gut motility .......................................................... 20 NICE approved medicines for specified indications are automatically added to this Formulary 2 Formulary 12 th Edition [v14.1] 1.3. Ulcer healing drugs ................................................................................................................... 21 1.3.1 H2 receptor antagonists ...................................................................................................... 21 1.3.3 Chelates and complexes ..................................................................................................... 21 1.3.4 Prostaglandin analogues .................................................................................................... 21 1.3.5 Proton pump inhibitors ...................................................................................................... 21 1.4. Acute diarrhoea ........................................................................................................................ 21 1.4.2 Antimotility drugs ...................................................................................................................... 21 1.5. Chronic diarrhoeas ................................................................................................................... 22 1.6. Laxatives .................................................................................................................................... 22 1.6.1 Bulk forming drugs .................................................................................................................... 22 1.6.2 Stimulant laxatives ..................................................................................................................... 22 1.6.3 Faecal softener ........................................................................................................................... 22 1.6.4 Osmotic laxatives ....................................................................................................................... 22 1.6.5 Bowel cleansing solutions.......................................................................................................... 23 1.7. Local preparations for anal and rectal disorders .................................................................. 23 1.7.1 Soothing haemorrhoidal preparations ........................................................................................ 23 1.7.3 Rectal sclerosants ...................................................................................................................... 23 1.8. Stoma care ................................................................................................................................. 23 1.9. Drugs affecting intestinal secretions ....................................................................................... 23 1.9.1. Drugs affecting biliary composition & flow ............................................................................. 23 1.9.4 Pancreatin ........................................................................................................................... 23 2: Cardiovascular system .................................................................................................................. 25 2.1 Positive inotropic drugs ............................................................................................................ 25 2.1.1 Cardiac glycosides ..................................................................................................................... 25 2.2 Diuretics ..................................................................................................................................... 25 2.2.1 Thiazides and related diuretics .................................................................................................. 25 2.2.2 Loop diuretics ............................................................................................................................ 25 2.2.3 Potassium-sparing diuretics ......................................................................................................